Skip to content
healthcare.dev

Anastrozole

NDC 76420-004, Anastrozole, tablet, from Asclemed USA, Inc..

Product NDC
76420-004
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090568
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANASTROZOLE1 mg/1

Pharmacologic classes

Aromatase Inhibitor [EPC]; Aromatase Inhibitors [MoA]

Package NDCNDC-11Package
76420-004-1276420000412120 TABLET in 1 BOTTLE, PLASTIC (76420-004-12)
76420-004-1576420000415150 TABLET in 1 BOTTLE, PLASTIC (76420-004-15)
76420-004-207642000042020 TABLET in 1 BOTTLE, PLASTIC (76420-004-20)
76420-004-307642000043030 TABLET in 1 BOTTLE, PLASTIC (76420-004-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b964f555-25d2-47ad-8942-f195f062445c

Use it

Look up 76420-004 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-004 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.